What does Lonafarnib (Zokinvy) do in plain English—and how does it work inside your body?
Lonafarnib is an FDA-regulated Farnesyltransferase Inhibitor (RxNorm RxCUI RXN-42358450-2753). Mechanistically, Biochemical activity of Lonafarnib reflects farnesyltransferase inhibitor pathway engagement after oral-route dosing (50 mg/1 Capsule and 75 mg/1 Capsule, manufactured/labeled by Sentynl Therapeutics, Inc., NDC 42358-450, 42358-475), supporting titratable maintenance pharmacotherapy. [1][2].
When your doctor writes a prescription for Lonafarnib (RxNorm RxCUI RXN-42358450-2753, also dispensed under brand names including Zokinvy), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Biochemical activity of Lonafarnib reflects farnesyltransferase inhibitor pathway engagement after oral-route dosing (50 mg/1 Capsule and 75 mg/1 Capsule, manufactured/labeled by Sentynl Therapeutics, Inc., NDC 42358-450, 42358-475), supporting titratable maintenance pharmacotherapy. [2].
Across real-world patient logs on dotMD (85% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Lonafarnib tablet bottle and confirm with your pharmacist that it matches your prescribed strength (50 mg/1 Capsule, 75 mg/1 Capsule).